ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,701 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentCadempinoNOVELTY PHARMA GALENICAL DEVELOPMENT AND DOCUMENTATION SA
NOVELTY PHARMA GALENICAL DEVELOPMENT AND DOCUMENTATION SA Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of Novelty Pharma is the production of customer-specific, tailor-made effervescent tablets.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

NOVELTY PHARMA GALENICAL DEVELOPMENT AND DOCUMENTATION SA

✓ Offered4
Custom effervescent tablets manufacturing
Contract manufacturing of customised effervescent tablets, with choice of technology, format, flavours, quantities and packaging; development of oral formulations and pharmaceutical dossiers.
Market-ready effervescent tablets
Effervescent tablets already ready to order, with the option to customise quantities and packaging; includes lines for vitamins, minerals, sports, immunity, well-being and generic effervescent products.
Development of pharmaceutical and nutraceutical dossiers
Development of pharmaceutical dossiers (EU CTD) and nutraceutical dossiers for product registration, with licensing of dossiers to partners and regulatory support pre- and post-production.
Development of effervescent solid oral dosage forms
Development of oral formulations in effervescent tablets, orodispersible tablets and soluble granules, with adaptation to customers’ specific needs and optimisation of the production process.
Trust & reputation

ranQ Trust Score of NOVELTY PHARMA GALENICAL DEVELOPMENT AND DOCUMENTATION SA: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

NOVELTY PHARMA GALENICAL DEVELOPMENT AND DOCUMENTATION SA has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
NOVELTY PHARMA GALENICAL DEVELOPMENT AND DOCUMENTATION SA scores 89.3 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
NOVELTY PHARMA GALENICAL DEVELOPMENT AND DOCUMENTATION SA scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
NOVELTY PHARMA GALENICAL DEVELOPMENT AND DOCUMENTATION SA scores 34.3 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.34.34%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

NOVELTY PHARMA GALENICAL DEVELOPMENT AND DOCUMENTATION SA reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once NOVELTY PHARMA GALENICAL DEVELOPMENT AND DOCUMENTATION SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

NOVELTY PHARMA GALENICAL DEVELOPMENT AND DOCUMENTATION SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank NOVELTY PHARMA GALENICAL DEVELOPMENT AND DOCUMENTATION SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of NOVELTY PHARMA GALENICAL DEVELOPMENT AND DOCUMENTATION SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Via al Mulino 22
6814 Cadempino
Opening hours
Mon
08:00 - 18:00
Tue
08:00 - 18:00
Wed
08:00 - 18:00
Thu
08:00 - 18:00
Fri
08:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-110.154.697
Founded
2003 · 23 years
Last commercial register change
June 25, 2024
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.100.06%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    OS
    Osmopharm SA
    Bedano
    AP
    Alpex Pharma SA
    Mezzovico
    SS
    Sensoptic SA
    Losone
    CS
    CoreQuest Sagl
    Lugano
    NN
    NAIE Natural Alternatives International Europe SA
    Manno
    DR
    Dedalos R&D
    Bellinzona
    AF
    Alpine Foundation for Life Sciences
    Olivone
    FS
    Fordras SA
    Lugano